AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 89 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,280,000 | -33.3% | 71,534 | -68.7% | 0.50% | -38.8% |
| Q3 2019 | $6,412,000 | -35.0% | 228,294 | -12.3% | 0.82% | +20.1% |
| Q2 2019 | $9,858,000 | +4.1% | 260,400 | +7.3% | 0.68% | +55.9% |
| Q1 2019 | $9,470,000 | +398.2% | 242,700 | +172.1% | 0.44% | +234.4% |
| Q4 2018 | $1,901,000 | +59.1% | 89,200 | +195.4% | 0.13% | +92.6% |
| Q3 2018 | $1,195,000 | -74.5% | 30,200 | -75.3% | 0.07% | -75.2% |
| Q2 2018 | $4,680,000 | -19.0% | 122,500 | -36.3% | 0.27% | -25.7% |
| Q1 2018 | $5,775,000 | +96.0% | 192,200 | +103.8% | 0.37% | +133.5% |
| Q4 2017 | $2,946,000 | +31.2% | 94,300 | +17.6% | 0.16% | +31.7% |
| Q3 2017 | $2,246,000 | +375.8% | 80,200 | +189.5% | 0.12% | +300.0% |
| Q1 2017 | $472,000 | – | 27,700 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |